Clinical Research

Analysis of factors influencing short⁃term adverse clinical outcome in cirrhotic patients with grade 2/3 ascites

  • Qingqing WANG ,
  • Jie DING ,
  • Haiwen LI ,
  • Zhijian DONG ,
  • Yiying WANG ,
  • Siqi LIU ,
  • Guoji CHANG ,
  • Lijuan HUA ,
  • Huayi CHEN ,
  • Shenghao LI ,
  • Yongrui. YANG
Expand
  • *.Department of Hepatopathy,the Third People's Hospital of Kunming Disease of Yunnan Province,Kunming 650041,China

Received date: 2023-10-10

  Online published: 2024-04-19

Abstract

Objective To explore the factors influencing the short?term adverse clinical outcome in patients hospitalized with grade 2/3 cirrhosis ascites. Methods 82 patients with grade 2/3 cirrhosis ascites in Kunming Third People's Hospital from December 2021 to February 2023 were used as research objects. Demographic data and first clinical data were collected. The clinical outcomes of the patients within 90 days after admission were followed up. Influencing factors of adverse clinical outcome were investigated by single factor screening and binary logistic regression analysis, including hospitalization over 28 days, unplanned readmission within 28 days, and death within 90 days (including death within 28 days). Finally, the diagnostic efficacy of the influencing factors were judged by ROC curve. Results (1)MELD?Na score (OR = 1.087, 95%CI: 1.006 ~ 1.175) and GGT (OR = 1.004, 95%CI: 1.002 ~ 1.007) were independent risk factors for hospitalization longer then 28 days, unplanned readmission within 28 days of admission and death within 28 days, respectively, all P < 0.05. BUN was an independent risk factor for all three conditions, with an OR of 1.111 (95% CI: 1.005 ~ 1.227), 1.115 (95%CI: 1.003 ~ 1.214) and 1.208 (95%CI: 1.057 ~ 1.382), all P < 0.05. (2)low serum chloride (OR = 0.875, 95%CI: 0.802 ~ 0.954) and low total CO2OR = 0.821, 95%CI: 0.690 ~ 0.976) were independent riak factors for death within 90 days, all P < 0.05. (3)The area under ROC curve of BUN combined with GGT predicted death within 28 days was 0.891; The area under curve of serum chloride combined with total CO2 predicted death within 90 days was 0.821, P < 0.05. Conclusion BUN combined with GGT had better predictive value for death within 28 days, serum chloride combined with total CO2 had better predictive value for death within 90 days.

Cite this article

Qingqing WANG , Jie DING , Haiwen LI , Zhijian DONG , Yiying WANG , Siqi LIU , Guoji CHANG , Lijuan HUA , Huayi CHEN , Shenghao LI , Yongrui. YANG . Analysis of factors influencing short⁃term adverse clinical outcome in cirrhotic patients with grade 2/3 ascites[J]. The Journal of Practical Medicine, 2024 , 40(8) : 1114 -1120 . DOI: 10.3969/j.issn.1006-5725.2024.08.016

References

1 ZACCHERINI G, TUFONI M, IANNONE G, et al. Management of Ascites in Patients with Cirrhosis: An Update[J]. J Clin Med, 2021, 10(22): 5226. doi:10.3390/jcm10225226
2 RUDLER M, MALLET M, SULTANIK P, et al. Optimal management of ascites[J]. Liver Int, 2020, 40 ():128-135. doi:10.1111/liv.14361
3 TONON M, PIANO S. Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences[J]. Med Clin North Am, 2023, 107(3): 505-516. doi:10.1016/j.mcna.2022.12.004
4 中华医学会肝病学分会. 肝硬化腹水诊疗指南(2023年版)[J]. 中华肝脏病杂志, 2023, 31(8): 813-826. doi:10.3760/cma.j.cn501113-20230719-00011
5 TONON M, PIANO S, GAMBINO C G, et al. Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis[J]. Clin Gastroenterol Hepatol, 2021, 19(2): 358-366.e8. doi:10.1016/j.cgh.2020.03.065
6 THEODORAKOPOULOS T, KALAFATELI M, KALAMBOKIS G N, et al. Natural history of grade 1 ascites in patients with liver cirrhosis[J]. Ann Gastroenterol, 2021, 34(1): 93-103.
7 中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 实用肝脏病杂志, 2018, 21(1): 21-31. doi:10.3969/j.issn.1672-5069.2018.01.006
8 CELIK F, BEKTASB H. Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials[J]. Florence Nightingale J Nurs, 2021, 29(2): 250-262. doi:10.5152/fnjn.2021.19171
9 BROWN C, AKSAN N, MUIR A J. MELD-Na Accurately Predicts 6-Month Mortality in Patients With Decompensated Cirrhosis: Potential Trigger for Hospice Referral[J]. J Clin Gastroenterol, 2022, 56(10): 902-907. doi:10.1097/mcg.0000000000001642
10 TACKE F, KLINKER H, BOEKER K H W, et al. Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C-Registry[J]. Hepatol Commun, 2022, 6(9): 2488-2495. doi:10.1002/hep4.2015
11 HIRAI K, OOKAWARA S, MORINO J, et al. Relationship between serum total carbon dioxide concentration and bicarbonate concentration in patients undergoing hemodialysis[J]. Kidney Res Clin Pract, 2020, 39(4): 441-450. doi:10.23876/j.krcp.19.126
12 CHANDRA S, RAVULA S, ERRABELLI P, et al. No Good Deed: Acidosis in Chronic Kidney and Liver Disease[J]. J Ren Nutr, 2023, 33(3): 499-502. doi:10.1053/j.jrn.2022.12.008
13 DROLZ A, HORVATITS T, ROEDL K, et al. Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease[J]. Ann Intensive Care, 2018, 8(1): 48. doi:10.1186/s13613-018-0391-9
14 WANG J, LIU P H, XU P, et al. Hypochloremia as a novel adverse prognostic factor in acute liver failure[J]. Liver Int, 2022, 42(12): 2781-2790. doi:10.1111/liv.15449
15 SEMMLER G, SCHEINER B, BALCAR L, et al. Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosis[J]. Aliment Pharmacol Ther, 2023, 58(1): 71-79. doi:10.1111/apt.17507
16 JI Y, LI L. Lower serum chloride concentrations are associated with increased risk of mortality in critically ill cirrhotic patients: an analysis of the MIMIC-III database[J]. BMC Gastroenterol, 2021, 21(1): 200. doi:10.1186/s12876-021-01797-3
17 王海斌,李晖,陈晓蕾,等. 空腹血糖水平对乙型肝炎病毒相关慢加急性肝衰竭患者疾病转归的影响[J]. 实用医学杂志, 2023, 39(18): 2373-2378. doi:10.3969/j.issn.1006-5725.2023.18.015
18 HUNG T H, TSENG C W, TSAI C C, et al. Prognosis of hypoglycemia episode in cirrhotic patients during hospitalization[J]. BMC Gastroenterol, 2021, 21(1): 319. doi:10.1186/s12876-021-01895-2
19 田亚文,闫红林,贺娜,等. 终末期肝病合并肌少症发生机制及干预防治研究进展[J]. 肝脏, 2023, 28(2): 253-256. doi:10.3969/j.issn.1008-1704.2023.02.027
20 KINAI C, ZORI A G. Recent advances in pathophysiology, diagnosis and management of hepatorenal syndrome: A review[J]. World J Hepatol, 2023, 15(6): 741-754. doi:10.4254/wjh.v15.i6.741
21 ZHENG L, LU Y, WU J, et al. Development and validation of a prognostic nomogram model for ICU patients with alcohol-associated cirrhosis[J]. Dig Liver Dis, 2023, 55(4): 498-504. doi:10.1016/j.dld.2023.01.148
Outlines

/